Table 2 Key indicators for help seeking and access to malaria treatment in individuals with fever in the preceding two weeks
| Indicator |
Children (N = 80) |
Adults (N = 57) | P* | |||
|---|---|---|---|---|---|---|
| n | % (95% CI) | TDHS2 | n | % (95% CI) | ||
| Episodes treated | 80 | 100 (95.5–100) | 57 | 100 (93.7–100) | ||
| Medications and dosaging: 1 | ||||||
| Modern medicine | 80 | 100 (95.5–100) | 56 | 98.3 (90.6–100) | 0.416∞ | |
| Antimalarial drug (AM) | 71 | 88.8 (79.7–94.7) | 58.2 (88.6) | 47 | 82.5 (70.1–91.3) | 0.293§ |
| - SP | 38 | 47.5 (36.2–59.0) | 23.7 (33.8) | 25 | 43.9 (30.7–57.6) | 0.673§ |
| - SP correctly dosed | 13 | 16.25 (8.9–26.2) | 18 | 31.6 (19.9–45.2) | 0.035 § | |
| - amodiaquine | 10 | 12.5 (6.2–21.8) | 22.1 (29.3) | 5 | 8.8 (2.9–19.3) | 0.491§ |
| - amodiaquine correctly dosed | 5 | 6.3 (2.1–14.0) | 3 | 5.3 (1.1–14.6) | 1.000∞ | |
| - quinine | 43 | 53.8 (42.2–65.0) | 11.9 (23.5) | 23 | 40.4 (27.6–54.2) | 0.122§ |
| - other AM | 2 | 2.5 (0.3–8.7) | 1 | 1.8 (0.0–9.4) | 1.000∞ | |
| Antipyretic only | 9 | 11.3 (5.3–20.3) | 9 | 15.8 (7.5–27.9) | 0.438§ | |
| Antibiotic | 8 | 10.0 (4.4–18.8) | 2 | 3.5 (0.4–12.1) | 0.194∞ | |
| Treatment sources: 1 | ||||||
| Health facility visit | 61 | 76.3 (65.4–85.1) | 32 | 56.1 (42.4–69.3) | 0.013 § | |
| AM from health facility | 43 | 53.8 (42.2–65.0) | 17 | 29.8 (18.4–43.4) | 0.005 § | |
| AM not from health facility | 28 | 35.0 (24.7–46.5) | 30 | 52.6 (39.0–66.0) | 0.040 § | |
| AM from drug store | 19 | 23.8 (15.0–34.6) | 26 | 45.6 (32.4–59.3) | 0.007 § | |
| AM from general shop | 8 | 10.0 (4.4–18.8) | 4 | 7.0 (2.0–17.0) | 0.761∞ | |
| AM from home stock (or relative/neighbour) | 10 | 12.5 (6.2–21.8) | 6 | 10.5 (4.0–21.5) | 0.723§ | |
| Exclusive home-management with AM3 | 14 | 17.5 (9.9–27.6) | 18 | 31.6 (19.9–45.2) | 0.055§ | |